Article
Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patients
medRxiv: the preprint server for health sciences · 2021 · S. Henriquez, author J. Zerbit, author T. Bruel, author A. Ouedrani, author D. Planas, author P. Deschamps, author I. Staropoli, author J. Hadjadj, author B. Varet, author F. Suarez, author N. Ermark, author D. Bouscary, author L. Willems, author G. Fouquet, author J. Decroocq, author P. Franchi, author B. Deau-Fischer, author B. Terrier, author J. Tamburini, author L. Chatenoud, author O. Schwartz, author M. Vignon, author
Key facts
| Title | Anti-CD38 therapy impairs SARS-CoV-2 vaccine response in multiple myeloma patients |
|---|---|
| First author | S. Henriquez, author J. Zerbit, author T. Bruel, author A. Ouedrani, author D. Planas, author P. Deschamps, author I. Staropoli, author J. Hadjadj, author B. Varet, author F. Suarez, author N. Ermark, author D. Bouscary, author L. Willems, author G. Fouquet, author J. Decroocq, author P. Franchi, author B. Deau-Fischer, author B. Terrier, author J. Tamburini, author L. Chatenoud, author O. Schwartz, author M. Vignon, author |
| Journal | medRxiv : the preprint server for health sciences |
| Published | Aug 12, 2021 |
| DOI | 10.1101/2021.08.08.21261769 |
| Devices mentioned | K103302 |
| Product codes mentioned | KIT, NJT, OOI, NDS |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1